Pulmonary hypertension in systemic sclerosis: Risk factors for progression and consequences for survival

Rheumatology

Volumn 40, Issue 4, 2001, Pages 453-459

  MacGregor, A J ^a,b   Canavan, R ^a   Knight, C ^a   Denton, C P ^a   Davar, J ^a   Coghlan, J ^a   Black, C M ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Echocardiography; Morbidity; Mortality; Systemic sclerosis; Vascular

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEALTH CENTER; HUMAN; IDIOPATHIC DISEASE; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL SPECIALIST; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; RISK FACTOR; SCREENING; SURVIVAL; SYSTEMIC SCLEROSIS; TIME;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SCLERODERMA, SYSTEMIC;

EID: 0035038492     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Mortality in systemic sclerosis (scleroderma)
2. Pulmonary hypertension in systemic autoimmune disease
3. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial
4. Primary pulmonary hypertension: Natural history and the importance of thrombosis
5. The effect of high dose calcium-channel blockers on survival in primary pulmonary hypertension
6. Doppler estimation of changes in pulmonary artery pressure during hypoxic breathing
7. Echocardiographic evaluation of pulmonary arterial hypertension in patients with progressive systemic sclerosis and related syndromes
8. Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis
9. Pulmonary arterial pressures in normal subjects. Effects of age and exercise
10. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis
11. Practical statistics for medical research
12. Statistical methods in cancer research
13. The pathophysiology of scleroderma involving the heart and respiratory system
14. Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma)
15. Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis
16. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis
17. Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: Association with serum anti-U3RNP antibody
18. Isolated diffusing capacity reduction in systemic sclerosis
19. Pulmonary hypertension in systemic sclerosis
20. Echocardiographic evaluation of pulmonary arterial hypertension in patients with progressive systemic sclerosis and related syndromes
21. Prevalence of pulmonary hypertension in limited and diffuse scleroderma
22. Mortality in systemic sclerosis (scleroderma)
23. Survival following the onset of scleroderma: Results from a retrospective inception cohort in the UK population
24. Pulmonary hypertension in systemic sclerosis: An analysis of 17 patients
25. Survival in patients with primary pulmonary hypertension
26. Survival in primary pulmonary hypertension. Validation of a prognostic equation
27. Prognostic and therapeutic considerations in clinical primary pulmonary hypertension
28. Elevated pulmonary artery pressure. An independent predictor of mortality